- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07789288
Hard Cervical Collar Use Following Posterior Cervical Fusion
August 24, 2026 updated by: Amjad Anaizi, Georgetown University
Impact of a Hard Cervical Collar Versus No Cervical Collar on Recovery Outcomes Following Posterior Cervical Fusion: A Prospective Study
Postoperative immobilization with a hard cervical collar following posterior cervical fusion remains common practice despite limited evidence demonstrating improved clinical outcomes.
This is a prospective, multi-site, randomized clinical trial evaluating postoperative hard cervical collar use following posterior cervical fusion for degenerative cervical spine disease.
Eligible patients will be randomized to either wear an FDA-approved hard cervical collar (Aspen Cervical Collar, Aspen Vista Cervical Collar, or Miami J Cervical Collar) for 6 weeks after surgery or receive no cervical collar.
Patient-reported outcomes will be collected before surgery and at 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months after surgery.
The primary outcome is radiographic fusion success at 12 months.
Secondary outcomes include neck disability, neck and arm pain, quality of life, patient satisfaction, wound infection, adverse events, and other postoperative complications.
Radiographic fusion will be evaluated by blinded radiologists.
The results of this study will help determine whether routine postoperative cervical collar use improves outcomes following posterior cervical fusion.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amjad Anaizi, MD
- Phone Number: 301-856-2323
- Email: Amjad.N.Anaizi@gunet.georgetown.edu
Study Locations
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20007
- Recruiting
- MedStar Georgetown University Hospital
-
Contact:
- Amjad Anaizi, MD
- Phone Number: 301-856-2323
- Email: Amjad.N.Anaizi@gunet.georgetown.edu
-
Washington D.C., District of Columbia, United States, 22209
- Recruiting
- MedStar Washington Hospital Center
-
Contact:
- Amjad Anaizi, MD
- Phone Number: 301-856-2323
- Email: Amjad.N.Anaizi@gunet.georgetown.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults aged 18 years or older
- Diagnosis of degenerative disk disease (DDD)
- Ability to provide informed consent
- Patients with cervical spondylotic myelopathy, cervical deformity, or pseudoarthrosis
Exclusion Criteria:
- Patients with trauma, tumors, or infections
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Collar
Hard Cervical Collar for 6 weeks
|
Participants randomized to this arm will wear a hard cervical collar continuously for 6 weeks following posterior cervical fusion.
The collar may be briefly removed for hygiene purposes.
FDA-approved cervical collars (Aspen Cervical Collar, Aspen Vista Cervical Collar, or Miami J Cervical Collar) will be used according to institutional practice.
|
|
No Intervention: No collar
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic fusion success
Time Frame: 3, 6, 12 months after surgery
|
Fusion success following posterior cervical fusion as determined by blinded radiographic evaluation
|
3, 6, 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neck Disability Index (NDI)
Time Frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months after surgery
|
Patient-reported neck disability measured using the Neck Disability Index survey
|
Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months after surgery
|
|
EQ-5D Quality of Life
Time Frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
|
Patient-reported survey
|
Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
|
|
Numeric Rating Scale (NRS) for Neck Pain
Time Frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
|
Patient-reported survey
|
Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
|
|
Numeric Rating Scale (NRS) for Arm Pain
Time Frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
|
Patient-reported survey
|
Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
|
|
North American Spine Society (NASS) Patient Satisfaction Index
Time Frame: 6 weeks, 12 weeks, 6 months, and 12 months
|
Patient-reported survey
|
6 weeks, 12 weeks, 6 months, and 12 months
|
|
Wound infection rate
Time Frame: up to 12 months after surgery
|
up to 12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 3, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
August 24, 2026
First Submitted That Met QC Criteria
August 24, 2026
First Posted (Actual)
August 27, 2026
Study Record Updates
Last Update Posted (Actual)
August 27, 2026
Last Update Submitted That Met QC Criteria
August 24, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00009444
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.